Enzon Pharmaceuticals Inc (ENZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -979 | 5,849 | 5,445 | -1,126 | 21,637 |
| Income taxes - deferred | N/A | N/A | 3,362 | 7,749 | -11,111 |
| Accounts receivable | 7,000 | -7,000 | N/A | N/A | N/A |
| Other Working Capital | 7,884 | -6,827 | -2,336 | -4,024 | 4,152 |
| Other Operating Activity | -7,000 | 7,000 | 0 | 0 | 0 |
| Operating Cash Flow | $6,905 | $-978 | $6,471 | $2,599 | $14,678 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -7,959 | N/A | -6,632 | -6,632 | -37,562 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -6 |
| Financing Cash Flow | $-7,959 | $N/A | $-6,632 | $-6,632 | $-37,568 |
| Beginning Cash Position | 6,500 | 7,478 | 7,639 | 11,672 | 34,562 |
| End Cash Position | 5,446 | 6,500 | 7,478 | 7,639 | 11,672 |
| Net Cash Flow | $-1,054 | $-978 | $-161 | $-4,033 | $-22,890 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,905 | -978 | 6,471 | 2,599 | 14,678 |
| Free Cash Flow | 6,905 | -978 | 6,471 | 2,599 | 14,678 |